Manganous-manganic oxide-lactalbumin nanosphere and preparation and application thereof

The invention belongs to the field of nanomaterial preparation and biological medicine and particularly relates to a manganous-manganic oxide-lactalbumin (Mn3O4-LA) nanosphere and preparation and an application thereof. The Mn3O4-LA nanosphere is prepared through self-assembly of oleic acid-modified...

Full description

Saved in:
Bibliographic Details
Main Authors ZHU CHUNLING, XIE ZENGHONG, LIN XUCONG, CAO TING
Format Patent
LanguageChinese
English
Published 07.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention belongs to the field of nanomaterial preparation and biological medicine and particularly relates to a manganous-manganic oxide-lactalbumin (Mn3O4-LA) nanosphere and preparation and an application thereof. The Mn3O4-LA nanosphere is prepared through self-assembly of oleic acid-modified hydrophobic Mn3O4 nanoparticles and alpha-LA after enzyme hydrolysis and DTT treatment through hydrophobic interaction, wherein the mean dimension is 120-140nm, the surface is negatively charged and the dispersity in a water phase is good. The obtained Mn3O4-LA nanosphere has a nuclear magnetic imaging function, is capable of loading hydrophobic and/or hydrophilic drug molecules, and can be used for preparing a diagnosis and treatment agent integrating nuclear magnetic imaging diagnosis and drug transportation. 本发明属于纳米材料制备和生物医学领域,具体涉及种四氧化三锰-乳白蛋白(MnO-LA)纳米球及其制备与应用。所述MnO-LA纳米球是由油酸修饰的疏水性MnO纳米颗粒与酶水解、DTT处理后的α-LA通过疏水作用自组装而成;其平均尺寸为120~140nm,表面带负电,在水相中分散性良好。本发明所得MnO-LA纳米球不仅具有核磁成像功能,且其可负载疏水性和/或亲水性药物分子,能够用于制备集核磁成像诊断及药物传输为体的
Bibliography:Application Number: CN201710567159